API Immunosuppressive Tacrolimus Material Tacrolimus Powder Tacrolimus

China API Immunosuppressive Tacrolimus Material Tacrolimus Powder Tacrolimus, Find details about China Tacrolimus, Purity Tacrolimus from API Immunosuppressive Tacrolimus Material Tacrolimus Powder Tacrolimus

Basic Info.

Model NO.

Condavo-Tacrolimus

Name

Tacrolimus

Product Name

Tacrolimus Powder

Appearance

White Powder

Color

White Color

Test Method

HPLC UV

Storage

Cool Dry Place

Shelf Life

2 Years

CAS

104987-11-3

C44h69no12

804.031

Density

1.19

Melting Point

113-115c

Boiling Point

871.7 C at 760 Mmhg

Refractive Index

1.549

Flash Point

481c

Trademark

Condavo

Transport Package

1kg/ Aluminium Bag or 25kg/Drum; as Required

Specification

99%

Origin

Shaanxi

Model NO.

Condavo-Tacrolimus

Name

Tacrolimus

Product Name

Tacrolimus Powder

Appearance

White Powder

Color

White Color

Test Method

HPLC UV

Storage

Cool Dry Place

Shelf Life

2 Years

CAS

104987-11-3

C44h69no12

804.031

Density

1.19

Melting Point

113-115c

Boiling Point

871.7 C at 760 Mmhg

Refractive Index

1.549

Flash Point

481c

Trademark

Condavo

Transport Package

1kg/ Aluminium Bag or 25kg/Drum; as Required

Specification

99%

Origin

Shaanxi

Product Desciption

API Immunosuppressive Tacrolimus Material Tacrolimus powder Tacrolimus

API Immunosuppressive Tacrolimus Material Tacrolimus Powder Tacrolimus

Product Name	Tacrolimus
CAS	104987-11-3
Appearance	White crystalline powder
MF	C44H69NO12
MW	804.031
Purity	99%
Shelf Life	2 Years

Tacrolimus is an immunosuppressive drug used mainly after allogeneic organ transplant to lower the risk of organ rejection. It achieves this by inhibiting the production of interleukin-2, a molecule that promotes the development and proliferation of T cells, which are vital to the body's learned (or adaptive) immune response. Tacrolimus is also used in the treatment of other T cell-mediated diseases such as eczema (for which it is applied to the skin in a medicated ointment), severe refractory uveitis after bone marrow transplants, exacerbations of minimal change disease, Kimura's disease and the skin condition vitiligo.

API Immunosuppressive Tacrolimus Material Tacrolimus Powder Tacrolimus

API Immunosuppressive Tacrolimus Material Tacrolimus Powder Tacrolimus _{1. Tacrolimus is used with other medications to prevent rejection of a kidney, heart, or liver transplant.
2. Tacrolimus is also used in a topical preparation in the treatment of severe atopic dermatitis, severe refractory uveitis after bone marrow transplants, and the skin condition vitiligo.
3. Tacrolimus can be combined with steroids, azathioprine (Imuran Azasan) or mycophenolate mofetil (CellCept).}
API Immunosuppressive Tacrolimus Material Tacrolimus Powder Tacrolimus

Tacrolimus is an immunosuppressive drug whose main use is after organ transplant to reduce the activity of the patient's immune system and so the risk of organ rejection. It is also used in a topical preparation in the treatment of severe atopic dermatitis, severe refractory uveitis after bone marrow transplants and the skin condition vitiligo.

API Immunosuppressive Tacrolimus Material Tacrolimus Powder Tacrolimus